FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Forte Biosciences (NASDAQ: FBRX) reported Q2 EPS of ($9.52), versus ($0.30) reported last year.
We are very happy to have concluded the reverse merger on June 15th and in that process, brought on a very well-respected group of investors, including Alger, BVF Partners, Franklin... More

